Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
小核仁 RNA 加剧动脉粥样硬化的机制
基本信息
- 批准号:10670399
- 负责人:
- 金额:$ 58.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Adverse effectsAffectAgeAntiatherogenicAntioxidantsAntisense OligonucleotidesAortaApolipoprotein EArteriesAtherosclerosisBindingBone MarrowBone Marrow CellsBone Marrow TransplantationCarotid ArteriesCell ProliferationCellsClinical TrialsCongenic MiceEmbryoEnzymesFoam CellsGeneticGenetic Complementation TestGoalsGuide RNAHepaticHumanHybridsImmunityIn VitroInfectionInflammationInflammatoryInsulin ResistanceIntronsKnowledgeLecithinLigationListeriosisMacrophageMapsMediatingMessenger RNAMethodsMethylationMethyltransferaseMissionMitochondriaMolecular ChaperonesMusMutagenesisMyocardial InfarctionNADPH OxidaseOxidasesOxidative StressPredispositionProcessProductionProtein IsoformsProteinsRNAReactive Oxygen SpeciesResearchRibosomal ProteinsRibosomal RNARoleSignal TransductionSiteSmall Interfering RNASmall Nucleolar RNASmooth Muscle MyocytesStrokeSuperoxidesTNF geneTestingTissuesTransgenesTranslationsTransplantationUnited States National Institutes of HealthUntranslated RNAVascular Smooth Muscleatherogenesisburden of illnesscatalasecell motilitycohortcongeniccrosslinkcytochrome c oxidasedisabilityfibrillarinin vivomRNA Precursornew therapeutic targetnovelnovel therapeutic interventionoxidized low density lipoproteinprotein expressionrecruittranscriptometransdifferentiationwestern diet
项目摘要
Superoxide and other derivative reactive oxygen species (ROS) promote atherosclerosis (athero) as well as
vascular smooth muscle cell (SMC) and macrophage inflammatory signaling. Anti-atherogenic strategies
targeting O2--producing NADPH oxidases, however, increase susceptibility to infection. This project’s goal is to
discern novel mechanisms for constraining ROS-promoted atherogenesis while minimizing adverse effects on
immunity. One such mechanism may involve the ubiquitously expressed noncoding small nucleolar (sno)
RNAs from the ribosomal protein L13a (Rpl13a) locus: SNORD32A, SNORD33, SNORD34, and SNORD35A.
We found that these snoRNAs augment ROS levels and oxidative stress in vitro and in vivo. Our Preliminary
Studies with Rpl13a-snoRNA-/- (snoKO) mice and SMCs derived from them show: (1) snoKO SMCs have
lower levels of ROS, cell proliferation and migration than congenic WT SMCs. (2) Compared with WT SMCs,
snoKO SMCs express 5.7-fold more cytochrome C oxidase subunit 4 isoform 2 (COX4I2), which reduces
mitochondrial O2- production. (3) SnoKO carotid arteries develop less athero than WT carotids when
transplanted orthotopically into Apoe-/- mice. (4) Compared with Apoe-/- mice, snoKO/Apoe-/- mice develop
40% less brachiocephalic athero. (5) Compared with snoRNA+/+ brachiocephalic arteries or carotid grafts,
snoKO arteries demonstrate less SMC-to-foam-cell transdifferentiation, a process potentiated by ROS.
SnoRNAs bind to their target RNAs via an antisense domain, then recruit the enzyme fibrillarin, which effects
RNA 2’-O-methylation. SnoRNAs canonically modify ribosomal RNA; however, we discovered that at least one
of the Rpl13a snoRNAs can target mRNA for 2’-O-methylation—a process that alters mRNA abundance and
translation. Nonetheless, specific mRNAs that constitute targets for pro-oxidant effects of Rpl13a-snoRNAs
remain obscure. This project will therefore test the hypotheses that Rpl13a snoRNAs promote athero,
particularly by potentiating SMC-to-foam cell transdifferentiation, and that that Rpl13a-snoRNA-guided mRNA
2’-O-methylation affects protein expression of key ROS-regulating enzyme(s) in SMCs and Mφs, including
COX4I2. To do so, this project will compare athero in Rpl13a-snoRNA-/-/Apoe-/- versus Apoe-/- mice, and use
bone marrow transplantation to discern the roles of Rpl13a-snoRNAs in bone marrow-derived cells versus
arterial wall-derived cells. We will investigate how Rpl13a-snoRNAs affect foam cell formation in macrophages
and SMCs, and determine whether COX4I2 engenders lower ROS levels and inflammation in snoKO SMCs.
Finally, we will identify mRNA targets of Rpl13a-snoRNAs in SMCs and macrophages, by performing
transcriptome-wide mapping of 2’-O-methylation sites on mRNA from WT and Rpl13a-snoRNA-/- SMCs and
macrophages, by using the RibOxi-seq and crosslinking, ligation, and sequencing of hybrids (CLASH)
approach. By elucidating mechanisms by which snoRNAs regulate ROS in SMCs and macrophages, this
project should identify new therapeutic targets for athero.
超氧化物和其他衍生的活性氧物种(ROS)促进动脉粥样硬化(Athero)以及
血管平滑肌细胞(SMC)和巨噬细胞炎症信号。抗动脉粥样硬化策略
然而,以产生O2-的NADPH氧化酶为靶标会增加感染的敏感性。这个项目的目标是
识别抑制ROS促进的动脉粥样硬化的新机制,同时最大限度地减少对
豁免权。一种这样的机制可能涉及普遍表达的非编码小核仁(Sno)。
核糖体蛋白L13a(Rpl13a)基因座的RNA:SNORD32A、SNORD33、SNORD34和SNORD35A。
我们发现,这些snoRNAs在体外和体内都能增强ROS水平和氧化应激。我们的预赛
对Rpl13a-snoRNA-/-(SnoKO)小鼠及其来源的SMC的研究表明:(1)SnoKO SMC具有
ROS水平、细胞增殖和迁移能力低于同种WT SMC。(2)与WT SMCS相比,
SnoKO SMC表达的细胞色素C氧化酶亚基4异构体2(COX4I2)增加5.7倍,从而减少
线粒体产生O2-。(3)与WT颈动脉相比,SnoKO颈动脉的动脉粥样硬化程度较低
原位移植到APOE-/-小鼠体内。(4)与APOE-/-小鼠相比,snoKO/APOE-/-小鼠
头臂动脉粥样硬化减少40%。(5)与snoRNA+/+头臂动脉或颈动脉相比,
SnoKO动脉表现出较少的SMC到泡沫细胞的转分化,这一过程被ROS加强。
SnoRNAs通过反义结构域与其目标RNA结合,然后招募纤维素酶,从而影响
RNA2‘-O-甲基化。SnoRNAs典型地修饰核糖体RNA;然而,我们发现至少有一个
在Rpl13a中,snoRNAs可以靶向mRNA进行2‘-O-甲基化-这一过程改变了mRNA的丰度和
翻译。然而,构成Rpl13a-snoRNAs促氧化作用靶点的特定mRNAs
仍然默默无闻。因此,该项目将测试Rpl13a snoRNAs促进动脉粥样硬化的假设,
特别是通过增强SMC到泡沫细胞的转分化,以及Rpl13a-snoRNA引导的mRNA
2‘-O-甲基化影响SMC和MφS中关键ROS调节酶(S)的蛋白表达,包括
COX4I2。为此,该项目将比较Rpl13a-snoRNA-/-/APOE-/-和APOE-/-小鼠的动脉粥样硬化,并使用
骨髓移植对比研究Rpl13a-snoRNAs在骨髓源性细胞中的作用
动脉壁来源的细胞。我们将研究Rpl13a-snoRNAs如何影响巨噬细胞中泡沫细胞的形成
并确定COX4I2是否会降低snoKO SMC中的ROS水平和炎症反应。
最后,我们将确定rpl13a-snoRNAs在SMC和巨噬细胞中的mrna靶点,通过执行
WT和Rpl13a-snoRNA-/-SMC和RPL13a-snoRNA-/-SMC的2‘-O-甲基化位点的转录组定位
巨噬细胞,通过使用RibOxi-seq和杂交的交联物、连接和测序(CLASH)
接近。通过阐明snoRNAs调节SMC和巨噬细胞中ROS的机制,这
该项目应确定动脉粥样硬化的新治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NEIL J. FREEDMAN其他文献
NEIL J. FREEDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NEIL J. FREEDMAN', 18)}}的其他基金
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
小核仁 RNA 加剧动脉粥样硬化的机制
- 批准号:
10502380 - 财政年份:2022
- 资助金额:
$ 58.7万 - 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
- 批准号:
9765984 - 财政年份:2019
- 资助金额:
$ 58.7万 - 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
- 批准号:
9893026 - 财政年份:2019
- 资助金额:
$ 58.7万 - 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
- 批准号:
10349573 - 财政年份:2019
- 资助金额:
$ 58.7万 - 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
- 批准号:
10112295 - 财政年份:2019
- 资助金额:
$ 58.7万 - 项目类别:
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
去泛素酶 USP20 对 B-arrestin2 促动脉粥样硬化活性的调节
- 批准号:
8797106 - 财政年份:2014
- 资助金额:
$ 58.7万 - 项目类别:
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
去泛素酶 USP20 对 B-arrestin2 促动脉粥样硬化活性的调节
- 批准号:
8639259 - 财政年份:2014
- 资助金额:
$ 58.7万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 58.7万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 58.7万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 58.7万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 58.7万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 58.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 58.7万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 58.7万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 58.7万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 58.7万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 58.7万 - 项目类别:
Miscellaneous Programs